RPG Life Sciences Profit & Loss Annual

BSE: 532983 | NSE: RPGLIFE | ISIN: INE105J01010 | Sector: Biotechnology & Drugs

2,720.80 +26.05 (0.97%)Updated : 15 Sep 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	578.01	432.61	470.97	424.84
Other Net	8.15	1.15	-	4.80
Diluted Weighted Average Shares	1.65	1.65	1.65	1.65
Gain( Loss)on Saleof Assets	0.01	1.20	0.01	-0.78
Depreciation/ Amortization	21.48	21.43	17.07	15.50
Operating Income	129.51	220.82	111.08	87.97
Net Income	115.17	183.24	87.66	67.64
Income Availableto Com Excl Extra Ord	115.17	183.24	87.66	67.64
Other Operating Expenses Total	9.20	5.14	5.91	-
Net Income Before Taxes	154.20	232.88	117.84	91.68
Net Income After Taxes	115.17	183.24	87.66	67.64
Income Availableto Com Incl Extra Ord	115.17	183.24	87.66	67.64
Costof Revenue Total	280.35	241.58	208.56	184.52
Gross Profit	427.17	411.85	373.49	328.29
Interest Inc( Exp) Net- Non- Op Total	16.53	9.71	6.75	-0.31
Unusual Expense( Income)	-3.90	-82.60	-	-
Diluted Net Income	115.17	183.24	87.66	67.64
DPS- Common Stock Primary Issue	24.00	20.00	16.00	12.00
Provisionfor Income Taxes	39.03	49.64	30.18	24.04
period Type	-	-	-	-
Net Income Before Extra Items	115.17	183.24	87.66	67.64
Total Revenue	707.52	653.43	582.05	512.81
period Length	12.00	12.00	12.00	12.00
Revenue	707.52	653.43	582.05	512.81
Selling/ General/ Admin Expenses Total	270.88	247.06	239.43	224.82
Diluted Normalized EPS	67.87	70.92	53.00	41.25
Diluted EPS Excluding Extra Ord Items	69.64	110.79	53.00	40.90

*All figures in crores except per share values

272.00+6.05(2.27%)

1,260.00+20.50(1.65%)

11,053.00+157.00(1.44%)

1,196.80-29.75 (-2.43%)

185.95-2.60 (-1.38%)

Related News